Zi‐Ning Lei

Also affiliated with Sun Yat-sen University, The Seventh Affiliated Hospital of Sun Yat-sen University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance”.

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

Cancers(2020)10.3390/cancers12010186

N/A

0.574DataRank · unranked

45 citations

Yuqi Yang, Qiu‐Xu Teng, Jing‐Quan Wang, Zi‐Ning Lei, Jing-Qiu Wang +5 more

Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor

Biochemical Pharmacology(2020)10.1016/j.bcp.2020.113848

N/A

0.550DataRank · unranked

38 citations

Wei Zhang, Jing‐Quan Wang, Zi‐Ning Lei, Yunkai Zhang, Yi‐Jun Wang +5 more

Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

Acta Pharmaceutica Sinica B(2022)10.1016/j.apsb.2022.03.023

N/A

0.542DataRank · unranked

36 citations

Qiu‐Xu Teng, Shuai Wang, Zi‐Ning Lei, Huihui Hu, Huifang Lv +9 more

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00674

N/A

0.520DataRank · unranked

31 citations

Peng Zheng, Yuqi Yang, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei +7 more

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor

Frontiers in Cell and Developmental Biology(2021)10.3389/fcell.2021.697927

N/A

0.500DataRank · unranked

27 citations

Yuqi Yang, Jing‐Quan Wang, Silpa Narayanan, Zi‐Ning Lei, Qiu‐Xu Teng +3 more

Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line

Frontiers in Cell and Developmental Biology(2020)10.3389/fcell.2020.607275

N/A

0.494DataRank · unranked

26 citations

Qiu‐Xu Teng, Wei Zhang, Yingfang Fan, Jing‐Quan Wang, Chao‐Yun Cai +5 more

RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.

PubMed(2024)10.2478/jtim-2024-0011

N/A

0.373DataRank · unranked

11 citations

Qisi Lu, Yidong Li, Chao‐Yun Cai, Qiu-Xu Teng, Zi‐Ning Lei +5 more

ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1

Frontiers in Bioscience-Landmark(2022)10.31083/j.fbl2701005

N/A

0.345DataRank · unranked

9 citations

Yuqi Yang, Zi‐Ning Lei, Silpa Narayanan, Jing‐Quan Wang, Qiu‐Xu Teng +5 more

The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide

Cancers(2020)10.3390/cancers12071963

N/A

0DataRank · unranked

28 citations

Xiaofang Luo, Zi‐Ning Lei, Jing‐Quan Wang, John N.D. Wurpel, Zuodong Qin +2 more

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells

Frontiers in Cell and Developmental Biology(2020)10.3389/fcell.2020.00865

N/A

0DataRank · unranked

24 citations

Meng Zhang, Xiubin Ma, Jing‐Quan Wang, Zi‐Ning Lei, Qiu‐Xu Teng +5 more

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance

Frontiers in Pharmacology(2021)10.3389/fphar.2021.620874

N/A

0DataRank · unranked

14 citations

Zhuo‐Xun Wu, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei, Sabrina Lusvarghi +4 more

The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter

Frontiers in Pharmacology(2022)10.3389/fphar.2022.861642

N/A

0DataRank · unranked

19 citations

Zhuo‐Xun Wu, Zi‐Ning Lei, Qiu‐Xu Teng, Yuqi Yang, Charles R. Ashby +4 more

PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study

Molecular Cancer(2022)10.1186/s12943-022-01512-0

N/A

0DataRank · unranked

14 citations

Qiu‐Xu Teng, Zhuo‐Xun Wu, Jing‐Quan Wang, Zi‐Ning Lei, Sabrina Lusvarghi +4 more

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

Cancers(2020)10.3390/cancers12020466

N/A

0DataRank · unranked

54 citations

Jonathan Y. Li, Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui +5 more

Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss

Cell Research(2025)10.1038/s41422-024-01016-0

N/A

0DataRank · unranked

11 citations

Meng Chen, Kaidi Wang, Yujianan Chen, Yazhou Cui, Yangli Xie +21 more

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

Frontiers in Oncology(2020)10.3389/fonc.2020.00700

N/A

0DataRank · unranked

41 citations

Ning Ji, Qiu‐Xu Teng, Chao‐Yun Cai, Jing‐Quan Wang, Zhuo‐Xun Wu +5 more

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00932

N/A

0DataRank · unranked

11 citations

Yong Mao, Xing-Duo Dong, Zi‐Ning Lei, Yuqi Yang, Lizhu Lin +5 more

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

Cancer Communications(2020)10.1002/cac2.12040

N/A

0DataRank · unranked

40 citations

Ning Ji, Chao‐Yun Cai, Jing‐Quan Wang, Zi‐Ning Lei, Qiu‐Xu Teng +5 more

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

International Journal of Molecular Sciences(2020)10.3390/ijms21041387

N/A

0DataRank · unranked

37 citations

Dong‐Hua Yang, Yuqi Yang, Jing‐Quan Wang, Chao‐Yun Cai, Zi‐Ning Lei +5 more

Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance

Frontiers in Pharmacology(2020)10.3389/fphar.2020.01208

N/A

0DataRank · unranked

37 citations

Qiu‐Xu Teng, Jinyun Dong, Dong‐Hua Yang, Meifeng Wang, Wubliker Dessie +6 more

Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter

Frontiers in Oncology(2020)10.3389/fonc.2020.574861

N/A

0DataRank · unranked

35 citations

Pranav Gupta, Qingbin Cui, Yunali V. Ashar, Zhuo‐Xun Wu, Leli Zeng +6 more

Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor

Frontiers in Cell and Developmental Biology(2020)10.3389/fcell.2020.601400

N/A

0DataRank · unranked

32 citations

Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui, Han Fu +5 more